GNOM vs. USOY
GNOM (Global X Genomics & Biotechnology ETF) and USOY (Defiance Oil Enhanced Options Income ETF) are both exchange-traded funds - GNOM is a Health & Biotech Equities fund tracking the Solactive Genomics Index, while USOY is a Derivative Income fund actively managed by Defiance. GNOM is passively managed, while USOY is actively managed. Over the past year, GNOM returned 57.90% vs 54.64% for USOY. At a correlation of -0.11, they often move in opposite directions. GNOM charges 0.50%/yr vs 1.22%/yr for USOY.
Performance
GNOM vs. USOY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GNOM achieves a 11.56% return, which is significantly lower than USOY's 59.27% return.
GNOM
- 1D
- 3.47%
- 1M
- 11.33%
- YTD
- 11.56%
- 6M
- 9.34%
- 1Y
- 57.90%
- 3Y*
- 0.45%
- 5Y*
- -9.59%
- 10Y*
- —
USOY
- 1D
- -1.79%
- 1M
- -3.80%
- YTD
- 59.27%
- 6M
- 55.41%
- 1Y
- 54.64%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GNOM vs. USOY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
GNOM Global X Genomics & Biotechnology ETF | 11.56% | 18.65% | -6.81% |
USOY Defiance Oil Enhanced Options Income ETF | 59.27% | -7.93% | 7.27% |
Correlation
The correlation between GNOM and USOY is -0.29, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.29 |
Correlation (All Time) Calculated using the full available price history since May 13, 2024 | -0.11 |
The correlation between GNOM and USOY shifts across timeframes, from -0.29 (1 year) to -0.11 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GNOM vs. USOY — Risk / Return Rank
GNOM
USOY
GNOM vs. USOY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology ETF (GNOM) and Defiance Oil Enhanced Options Income ETF (USOY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GNOM | USOY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.38 | ||
| Sortino ratioReturn per unit of downside risk | +0.85 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.33 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 3.20 | 3.84 | -0.64 |
| Martin ratioReturn relative to average drawdown | 9.21 | 7.37 | +1.84 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| GNOM | USOY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.18 | 1.80 | +0.38 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.29 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.07 | 0.95 | -1.02 |
Drawdowns
GNOM vs. USOY - Drawdown Comparison
The maximum GNOM drawdown since its inception was -75.00%, which is greater than USOY's maximum drawdown of -17.46%. Use the drawdown chart below to compare losses from any high point for GNOM and USOY.
Loading charts...
Drawdown Indicators
| GNOM | USOY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.00% | -17.46% | -57.54% |
Max Drawdown (1Y)Largest decline over 1 year | -18.17% | -14.29% | -3.88% |
Max Drawdown (3Y)Largest decline over 3 years | -46.47% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -72.29% | — | — |
Current DrawdownCurrent decline from peak | -53.90% | -6.81% | -47.09% |
Average DrawdownAverage peak-to-trough decline | -40.56% | -6.47% | -34.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.30% | 7.43% | -1.13% |
Volatility
GNOM vs. USOY - Volatility Comparison
The current volatility for Global X Genomics & Biotechnology ETF (GNOM) is 8.77%, while Defiance Oil Enhanced Options Income ETF (USOY) has a volatility of 11.67%. This indicates that GNOM experiences smaller price fluctuations and is considered to be less risky than USOY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GNOM | USOY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.77% | 11.67% | -2.90% |
Volatility (6M)Calculated over the trailing 6-month period | 19.72% | 27.26% | -7.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.66% | 30.50% | -3.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.61% | 26.14% | +7.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.19% | 26.14% | +8.05% |
GNOM vs. USOY - Expense Ratio Comparison
GNOM has a 0.50% expense ratio, which is lower than USOY's 1.22% expense ratio.
Dividends
GNOM vs. USOY - Dividend Comparison
GNOM's dividend yield for the trailing twelve months is around 1.23%, less than USOY's 56.65% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
GNOM Global X Genomics & Biotechnology ETF | 1.23% | 1.37% | 0.00% | 0.00% | 0.00% | 0.03% | 0.14% |
USOY Defiance Oil Enhanced Options Income ETF | 56.65% | 104.32% | 48.60% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
GNOM and USOY have a correlation of -0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
USOY has higher volatility (11.67%) compared to GNOM (8.77%). In terms of maximum drawdown, GNOM dropped -75.00% vs USOY's -17.46%.
On 1-year performance, GNOM leads with 57.90% vs 54.64% for USOY. On fees, GNOM is cheaper at 0.50% per year. On volatility, GNOM has been the lower-risk option at 8.77%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, GNOM has performed better with a 57.90% return vs 54.64%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
GNOM is cheaper with a 0.50% expense ratio, compared with 1.22% for USOY.
USOY has the higher dividend yield at 56.65%, compared with 1.23% for GNOM.
GNOM is categorized as Health & Biotech Equities, while USOY is Derivative Income. They also come from different issuers: Global X and Defiance. Their fees differ too: 0.50% for GNOM and 1.22% for USOY.
GNOM currently has the higher Sharpe Ratio (2.18 vs 1.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GNOM and USOY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer